- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Profitable Climbers
Hong Kong Pharmaceuticals & Biotech Profitable Climbers
Results
10
10 companies
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$44.6b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$59.80
7D
4.9%
1Y
406.8%
WuXi XDC Cayman
Market Cap: HK$76.1b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$60.50
7D
-1.8%
1Y
90.0%
XtalPi Holdings
Market Cap: HK$43.7b
An investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.
2228
HK$9.98
7D
4.6%
1Y
119.3%
Sihuan Pharmaceutical Holdings Group
Market Cap: HK$12.0b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China and the United States.
460
HK$1.31
7D
-5.8%
1Y
107.9%
CanSino Biologics
Market Cap: HK$14.1b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$34.58
7D
4.7%
1Y
17.2%
JBM (Healthcare)
Market Cap: HK$2.2b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.64
7D
-0.8%
1Y
26.9%
Innovent Biologics
Market Cap: HK$158.8b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$91.10
7D
4.8%
1Y
92.8%
SSY Group
Market Cap: HK$7.2b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.43
7D
-2.0%
1Y
-18.5%
Viva Biotech Holdings
Market Cap: HK$4.0b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$1.81
7D
-1.6%
1Y
34.1%
China Medical System Holdings
Market Cap: HK$33.7b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$13.57
7D
-2.2%
1Y
84.6%